Description

IMPORTANT NOTE:
There has been a change in label of Forteo (teriparatide injection) from 600 mcg/2.4 mL to 560 mcg/2.24 mL. This change does not impact the efficacy or safety or dosing of the product. Please see the full Prescribing Information for more information or talk to your Healthcare Professional.

For patients at high risk for fracture due to osteoporosis

FORTEO (teriparatide injection) can help reduce your risk of having another fracture*

FORTEO is a prescription medicine used to treat postmenopausal women who have osteoporosis who are at high risk for having broken bones (fractures) or who cannot use other osteoporosis treatments. FORTEO can lessen the chance of broken bones (fractures) in the spine and other bones in postmenopausal women with osteoporosis. FORTEO is used to increase the bone mass in men with primary or hypogonadal osteoporosis who are at high risk for having broken bones (fractures) or who cannot use other osteoporosis treatments. FORTEO is used to treat both men and women with osteoporosis due to use of glucocorticoid medicines, such as prednisone, for several months, who are at high risk for having broken bones (fractures) or who cannot use other osteoporosis treatments.

*Only proven in postmenopausal women with osteoporosis. All women took calcium and vitamin D daily.

Here is some important safety information you should know about FORTEO:

Possible bone cancer. During drug testing, the medicine in FORTEO caused some rats to develop a bone cancer called osteosarcoma. Studies in people have not shown that FORTEO increases your chance of getting osteosarcoma. There is little information about the chance of getting osteosarcoma in patients using FORTEO beyond 2 years.